Cubist Systematic Strategies’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-179,659
Closed -$895K 3194
2025
Q2
$895K Sell
179,659
-195,989
-52% -$851K ﹤0.01% 1999
2025
Q1
$1.66M Buy
375,648
+223,336
+147% +$1.05M 0.01% 1531
2024
Q4
$708K Buy
+152,312
New +$837K ﹤0.01% 2005
2024
Q3
Sell
-12,446
Closed -$97.1K 3167
2024
Q2
$97.1K Sell
12,446
-479,249
-97% -$3.55M ﹤0.01% 2633
2024
Q1
$3.49M Buy
491,695
+189,894
+63% +$1.26M 0.02% 1218
2023
Q4
$2.02M Sell
301,801
-153,093
-34% -$862K 0.01% 1501
2023
Q3
$2.56M Buy
454,894
+316,598
+229% +$2.11M 0.02% 1193
2023
Q2
$763K Sell
138,296
-106,956
-44% -$576K 0.01% 2121
2023
Q1
$1.53M Sell
245,252
-6,091
-2% -$34K 0.01% 1852
2022
Q4
$1.17M Sell
251,343
-143,678
-36% -$708K 0.01% 2290
2022
Q3
$1.84M Sell
395,021
-40,181
-9% -$253K 0.01% 2087
2022
Q2
$2.58M Buy
435,202
+162,161
+59% +$1.8M 0.02% 1610
2022
Q1
$5.28M Buy
273,041
+201,897
+284% +$4.63M 0.04% 689
2021
Q4
$2.33M Buy
71,144
+55,535
+356% +$2.23M 0.02% 1232
2021
Q3
$640K Buy
+15,609
New +$566K 0.01% 1856
2021
Q1
Sell
-5,221
Closed -$211K 2879
2020
Q4
$211K Buy
+5,221
New +$240K ﹤0.01% 2215

Other funds holding GDRX

Cubist Systematic Strategies's GDRX Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of GoodRx Holdings (GDRX) in Q3 2025, closing a stake of 179,659 shares — an estimated $895K sold.

Cubist Systematic Strategies first reported a position in GDRX in Q4 2020 and held it in 16 quarters. The position peaked at $5.28M in Q1 2022. 161 funds tracked by Wall St. Rank hold GDRX as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining GoodRx Holdings position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 179,659 GoodRx Holdings shares in Q3 2025, an estimated $895K.
  • Cubist Systematic Strategies first reported a position in GoodRx Holdings in Q4 2020 and held it in 16 quarters.
  • Cubist Systematic Strategies's GoodRx Holdings position peaked at $5.28M in Q1 2022.
  • 161 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.